AC ALLIEDCEL

Serial Number 97821655
Registration 7446059
700

Registration Progress

Application Filed
Mar 3, 2023
Under Examination
Dec 19, 2023
Approved for Publication
Oct 24, 2023
Published for Opposition
Apr 30, 2024
Registered
Jul 16, 2024

Trademark Image

AC ALLIEDCEL

Basic Information

Serial Number
97821655
Registration Number
7446059
Filing Date
March 3, 2023
Registration Date
July 16, 2024
Published for Opposition
April 30, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 16, 2024
Registration
Registered
Classes
005 010 035 040
+2 more

Rights Holder

Sysmex Corporation

03
Address
1-5-1, Wakinohama-kaigandori, Chuo-ku,
Kobe, Hyogo 651-0073
JP

Ownership History

Sysmex Corporation

Original Applicant
03
Kobe, Hyogo JP

Sysmex Corporation

Owner at Publication
03
Kobe, Hyogo JP

Sysmex Corporation

Original Registrant
03
Kobe, Hyogo JP

Legal Representation

Attorney
Jonathan Brown

USPTO Deadlines

Next Deadline
1812 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-07-16)
Due Date
July 16, 2030
Grace Period Ends
January 16, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

33 events
Date Code Type Description Documents
Jul 16, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 16, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 16, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 30, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 30, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 10, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 27, 2024 OTHE I CASE RETURNED TO EXAMINATION Loading...
Mar 27, 2024 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Feb 5, 2024 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Feb 5, 2024 PCBG O PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Loading...
Jan 31, 2024 APET A ASSIGNED TO PETITION STAFF Loading...
Dec 28, 2023 TPAD I TEAS PETITION TO AMEND BASIS RECEIVED Loading...
Dec 19, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 24, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 24, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 4, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 19, 2023 FIXD O ELECTRONIC RECORD REVIEW COMPLETE Loading...
Sep 15, 2023 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Sep 11, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 28, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 27, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 27, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 16, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 16, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 16, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 10, 2023 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Mar 31, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 24, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 23, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 14, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 14, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 14, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 7, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer or blood diseases; biological tissue cultures for medical purposes; pharmaceutical preparations or biological preparations for diagnostic or medical purposes, namely, pharmaceutical and biological preparations for the treatment of cancer or blood diseases; regenerative medical products, namely blood preparations using stem cells; stem cells for medical purposes; stem cells for veterinary purposes; regenerative medical products of stem cells, namely blood-derived products; pharmaceutical preparations of stem cells, namely, pharmaceutical preparations of stem cells derived from umbilical cord blood or peripheral blood and expanded in culture for use in stem cell transplantation and regenerative therapy, in medical or clinical use; transplants, being living tissues, for medical use, namely, gene therapy products, namely, genetically engineered tissues for transplant purposes; cells for medical use; blood preparations for medical purposes, namely, blood substitute for medical use; diagnostic reagents for medical purposes; chemical reagents for medical purposes
Class 010
apparatus for the regeneration of stem cells for medical purposes; blood transfusion apparatus for medical purposes; medical tubing for transfusions
Class 035
retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services featuring chemicals; retail store services featuring medical apparatus or instruments
Class 040
Custom manufacture or production of pharmaceuticals; custom manufacture or production of pharmaceutical materials; Custom manufacture or production of chemicals; custom manufacture of medical devices for others; custom manufacture of scientific devices for others
Class 042
Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; testing, inspection or research of medical apparatus or instruments; medical research; Scientific research in the nature of conducting clinical trials for others; scientific research; stem cell research services
Class 044
Providing medical information; regenerative medicine services; health care services, namely, therapy and diagnostic services using regenerative medicine; health care services, namely, therapy and diagnostic services using cell therapy; blood and tissue bank services, namely, collection and preservation of biological tissue, blood, and cells; stem cell bank services; medical services relating to the removal, treatment and processing of human cells; medical services relating to the removal, treatment and processing of human blood

Additional Information

Design Mark
The mark consists of the wording "ALLIEDCEL" and a design of the overlapping stylized letters "AC" to the left of the wording. The letter "A" in the design is in the shape of a blue triangle and the letter "C" consists of an incomplete circle in green. The unitary word "ALLIEDCEL" appearing in a stylized font. The letter "A" in the term is in blue and the letter "C" is in green. The remaining letters in the term "ALLIEDCEL" are in black. The white color in the mark represents background and is not claimed as a feature of the mark.
Color Claim
The color(s) blue, green and black is/are claimed as a feature of the mark.

Classification

International Classes
005 010 035 040 042 044